Download the Complete Report Here By Brandon Hornback Aurora Cannabis Inc. (NASDAQ: ACB) smoked another quarter, led by ...

Edmonton, AB, and Stamford, CT – August 1, 2024 - Aurora Cannabis Inc. ("Aurora") (NASDAQ | TSX: ACB), a leading Canadian-based global medical cannabis company, and Vectura Fertin Pharma, Inc., an ...

As a result, other than as referenced below, each of the director nominees were elected as directors of Aurora to serve until the close of the next annual meeting of Aurora shareholders or until their ...

Canadian pot producer Aurora Cannabis Inc , on Tuesday forecast first-quarter revenue below analysts' estimates, sending its U.S-listed shares tumbling 15%.

Recent Performance and Market Conditions: Aurora’s stock closed at CAD 6.36, marking a 0.75% drop over the past week and a 1.18% decrease over the past month, with an annual decline of 0.62%. These ...

EDMONTON, AB, Oct. 16, 2024/ CNW/ - Aurora Cannabis Inc., (NASDAQ: ACB) (TSX: ACB) – the Canadian based global leader in medical cannabis, in conjunction with MedReleaf Australia, is pleased to ...

Expands YoY Global Medical Cannabis Net Revenue 1 by 15% to Record $70.5 million Increases International Medical Cannabis Net Revenue 1 by 22% to Record ...

Q2 2026 Earnings Call November 5, 2025 8:00 AM ESTCompany ParticipantsSimona King - Chief Financial OfficerMiguel Martin - ...

Aurora Cannabis Inc. closed 37.77% below its 52-week high of $6.91, which the company reached on February 10th.

EDMONTON — Aurora Cannabis Inc. says it has become aware of “misinformation” posted on a news website, incorrectly stating that Aurora has agreed to acquire New Zealand based MedLeaf Therapeutics. The ...

Aurora Cannabis Inc. reported fiscal second-quarter 2026 revenue of $90.4 million, an 11% increase year-over-year, driven largely by record global medical marijuana sales. The Edmonton-based company ...